Table 2.
Role in decision-making at different points in the prevention of mother-to-child HIV transmission (PMTCT) cascade
| Maternal antiretroviral use in pregnancy | Infant antiretroviral prophylaxis | Infant testing | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Yes N=190 n (%) |
No N=86 n (%) |
p | Yes N=175 n (%) |
No N=100 n (%) |
p | Yes N=160 n (%) |
No N=117 n (%) |
p | |
| Mother’s healthcare | 0.66 | 0.87 | 0.04 | ||||||
| Active role | 148 (68.2) | 69 (31.8) | 138 (63.9) | 78 (36.1) | 133 (61.0) | 85 (39.0) | |||
| No active role | 42 (71.2) | 17 (28.8) | 37 (62.7) | 22 (37.3) | 27 (45.8) | 32 (54.2) | |||
| Household purchases | 0.62 | 0.96 | 0.04 | ||||||
| Active role | 110 (70.1) | 47 (29.9) | 100 (64.1) | 56 (35.9) | 99 (63.1) | 58 (36.9) | |||
| No active role | 78 (67.2) | 38 (32.8) | 74 (63.8) | 42 (36.2) | 59 (50.4) | 58 (49.6) | |||
| Children’s school | 0.64 | 0.98 | 0.05 | ||||||
| Active role | 114 (69.9) | 49 (30.1) | 103 (63.6) | 59 (36.4) | 102 (62.6) | 61 (37.4) | |||
| No active role | 76 (67.3) | 37 (32.7) | 72 (63.7) | 41 (36.3) | 58 (50.9) | 56 (49.1) | |||
| Children’s healthcare | 0.58 | 0.95 | 0.07 | ||||||
| Active role | 115 (70.1) | 49 (29.9) | 104 (63.8) | 59 (36.2) | 102 (62.2) | 62 (37.8) | |||
| No active role | 75 (67.0) | 37 (33.0) | 71 (63.4) | 41 (36.6) | 58 (51.3) | 55 (48.7) | |||
| Composite outcome | 0.66 | 0.82 | 0.04 | ||||||
| Active role in at least one domain | 146 (68.2) | 68 (31.8) | 137 (64.3) | 76 (35.7) | 131 (60.9) | 84 (39.1) | |||
| No active role reported in any domain | 42 (71.2) | 17 (28.8) | 37 (62.7) | 22 (37.3) | 27 (45.8) | 32 (54.2) | |||